Researchers have developed a compound that is effective against common bacteria that can lead to rare, dangerous illnesses. Researchers at Washington University School of Medicine in St. Louis have ...
Increasingly, hospitalized patients contract infections that evade current antibiotics including colistin, long used as a last treatment option. The discovery of a new colistin variant might make it ...